Skip to main content

Table 6 Comparison of clinical and biological variables at ICU admission between survivor and non-survivor patients with severe pneumonia

From: Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

  Survivors
43
Non-survivors
15
p value
Sex (male/female) 28/15 8/7  
Age, years (mean ± SD) 62.4 ± 14 60.2 ± 10.9 0.22
SAPS II, median (IQR) 45(34–59) 66 (55–73) <0.003
SOFA, median (IQR) 8 (6–11) 12 (9–13) <0.005
Creatininemia, median (IQR), (μmol/L) 52 (33–100) 46 (30–95) 0.62
Positive HAA, n 11 4  
PCT, median (IQR), (ng/mL) 0.97 (0.27–8) 5.2 (2–16.8) 0.025
hsCRP, median (IQR), (mg/L) 102 (65–242) 180 (95–278) 0.29
Presepsin, median (IQR), (pg/mL) 999 (570–2020) 1821 (1310–2837) 0.006
ICU length of stay, median (IQR), (days) 6 (4–11) 5 (2–9) 0.36
  1. SAPS simplified acute physiology score, SOFA sequential organ failure assessment score, PCT procalcitonin, hsCRP high-sensitivity C-reactive protein
  2. p: differences between survivor and non-survivor patients